1 minute read
Industry Trends: By The Numbers
Next Article
2,314 Compiled by Cari Kraft, Jacobs Management Group, Inc. EXABYTES
Amount of healthcare data estimated to be generated in 2020
Only 153 exabytes (one exabyte = one billion gigabytes) were produced in 2013. The growth of this data is predicted to be at least 48 percent annually. Source: Stanford Medicine 2017 Health Trends Report: Harnessing the Power of Data in Health.
Projected U.S. per-person spending on medicines through 2022
Per capita spending on medicines is expected to decline by end of 2018 and stay steady at about $800 per capita through 2022. Figure is adjusted for population growth, rising GDP, and estimates of manufacturer revenue. Source: IQVIA Institute for Human Data Science, 2018 and Beyond: Outlook and Turning Points, March 2018
$105B
U.S. brand sales expected to face generic or biosimilar competition
Ninety percent of all prescriptions in the U.S. are filled with generics today. A report by industry association PhRMA suggests that $105B of brand sales will face generic or biosimilar competition by 2022.
$800
Source: PhRMA, 2018 Profile: Biopharmaceutical Research Industry
12.2%
Percent of Americans uninsured as of 4Q 2017
This figure is down from 16% in 2010, but up from the low of 10.9% in Q3 2016. SOURCE: Gallup-Sharecare Wellbeing Index
35
Percent of physicians now practice some form of telemedicine
Key finding from the Physicians Foundation Survey of 9,000 U.S. physicians. Source: Physicians Foundation Survey by Merrit Hawkins, September 2018
Drug shortages in 2017
The FDA helped to prevent 132 drug shortages in 2017, with only 35 shortages remaining. This was down from a high of 251 non-remediated shortages in 2011. Source: FDA, “FDA is Advancing New Efforts to Address Drug
18.5 %
Shortages,” November 2018
55%
Growth of 65+ U.S. population by 2030
The elder population of the United States will have increased by 55% in the next 20 years. Source: Source: U.S. Census Bureau
